博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688767 博拓生物

已收盘 11-22 15:00:01

{"stockData":{"symbol":"688767","market":"SH","secType":"STK","nameCN":"博拓生物","latestPrice":30.59,"timestamp":1732258801000,"preClose":32.87,"halted":0,"volume":1565057,"delay":0,"floatShares":107000000,"shares":107000000,"eps":0.9778,"marketStatus":"已收盘","marketStatusCode":5,"change":-2.28,"latestTime":"11-22 15:00:01","open":32.65,"high":32.65,"low":30.46,"amount":49263200,"amplitude":0.0666,"askPrice":30.59,"askSize":5,"bidPrice":30.55,"bidSize":25,"shortable":0,"etf":0,"ttmEps":0.9778,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":32.87,"symbolType":"stock_kcb","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":36.16,"lowLimit":29.58,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":106666667,"pbRate":1.37,"roa":"--","roe":"3.74%","epsLYR":1,"committee":0.156146,"marketValue":3263000000,"floatMarketCap":3263000000,"peRate":31.284516,"changeRate":-0.0694,"turnoverRate":0.0147,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-11-25。","afterMarket":{"amount":0,"volume":0,"close":30.59,"buyVolume":0,"sellVolume":0,"time":1732260839464,"indexStatus":"已收盘 11-22 15:30:00","preClose":32.87}},"requestUrl":"/m/hq/s/688767/tweets","defaultTab":"tweets","newsList":[{"id":"2485400143","title":"博拓生物跌5% 主力净流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2485400143","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485400143?lang=zh_cn&edition=full","pubTime":"2024-11-22 13:14","pubTimestamp":1732252461,"startTime":"0","endTime":"0","summary":"11月22日，博拓生物股价大幅下跌，截至13点14分，博拓生物下跌5.20%，报31.16元/股，成交2684万元，换手率0.79%，振幅4.53%。资金动向截止发稿，博拓生物获得主力净流出146万元，其中超大单流入1万元，大单流出146万元。主营业务及业绩博拓生物公司主营业务为从事POCT诊断试剂的研发、生产和销售。最新财报显示，今年三季报，博拓生物实现营业收入3.89亿元，同比增长24.51%，净利润为8,921.17万元，同比减少2.53%，基本每股收益为0.85元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122131437a24d0256&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122131437a24d0256&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2485430963","title":"博拓生物11月21日主力资金流入164万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2485430963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485430963?lang=zh_cn&edition=full","pubTime":"2024-11-21 15:19","pubTimestamp":1732173595,"startTime":"0","endTime":"0","summary":"11月21日, 博拓生物股价跌1.17%，报收32.87元，成交金额5004万元，换手率1.43%，振幅3.40%，量比1.09。博拓生物今日主力资金净流入164万元，连续3日净流入，上一交易日主力净流入90万元，今日环比增加82.22%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为42.86%，平均涨幅为2.27%。该股近5个交易日上涨9.24%，主力资金累计净流入1278万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1749万元，其中净流入天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153049abd40c1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153049abd40c1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2484953605","title":"博拓生物股价涨5% 沙特考察团关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2484953605","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484953605?lang=zh_cn&edition=full","pubTime":"2024-11-19 09:41","pubTimestamp":1731980490,"startTime":"0","endTime":"0","summary":"11月19日，博拓生物股价大幅上涨，截至09点41分，博拓生物上涨5.23%，报31.39元/股，突破30元整数关口，成交714万元，换手率0.22%，振幅4.69%。融资融券方面，博拓生物11月15日获得融资净买入102万元，当日该股融资余额为6769万元，当较前一日增加1.53%。最新财报显示，今年三季报，博拓生物实现营业收入3.89亿元，同比增长24.51%，净利润为8,921.17万元，同比减少2.53%，基本每股收益为0.85元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119094152a24455e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119094152a24455e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2482627242","title":"博拓生物：做好呼吸道疾病感染高发季的产品储备与供应","url":"https://stock-news.laohu8.com/highlight/detail?id=2482627242","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482627242?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:50","pubTimestamp":1731315031,"startTime":"0","endTime":"0","summary":"11月11日，博拓生物举办2024年第三季度业绩说明会。会上管理层介绍，公司新募投项目微流控荧光检测平台项目相关立项项目正在前期准备工作中，项目将会稳步推进实施。2024年前三季度公司免疫层析胶体金类传染病检测、毒品检测产品为公司贡献较大收入。在国内市场方面根据国家列管政策开发新的毒品检测试剂，做好呼吸道疾病感染高发季的产品储备与供应，同时进一步完善荧光免疫层析产品注册证书，进一步丰富产品资源。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111165213a22c0570&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111165213a22c0570&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2479876095","title":"博拓生物（688767）2024年三季报简析：增收不增利，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2479876095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479876095?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:28","pubTimestamp":1730327288,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期博拓生物发布2024年三季报。截至本报告期末，公司营业总收入3.89亿元，同比上升24.51%，归母净利润8921.17万元，同比下降2.53%。本报告期博拓生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达899.09%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100008140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2479479253","title":"博拓生物：计提减值准备合计对公司2024年前三季度合并利润总额影响约1074万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479479253","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479479253?lang=zh_cn&edition=full","pubTime":"2024-10-29 18:06","pubTimestamp":1730196419,"startTime":"0","endTime":"0","summary":"每经AI快讯，博拓生物（SH 688767，收盘价：29.41元）10月29日晚间发布公告称，公司本次计提减值准备分别计入资产减值损失和信用减值损失科目，合计对公司2024年前三季度合并利润总额影响约1074万元。博拓生物的董事长是陈音龙，男，62岁，学历背景为大专；总经理是吴淑江，男，47岁，学历背景为硕士。截至发稿，博拓生物市值为31亿元。道达号（daoda1997）“个股趋势”提醒：1. 近30日内无机构对博拓生物进行调研。每经头条（nbdtoutiao）——华尔街力挺，白银“王者归来”，价格创12年来新高！是否将继续“补涨”？个人投资者如何操作？(记者 曾健辉)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029180811ab7e6e83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029180811ab7e6e83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2479967426","title":"博拓生物10月29日主力资金流入27万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2479967426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479967426?lang=zh_cn&edition=full","pubTime":"2024-10-29 15:19","pubTimestamp":1730186389,"startTime":"0","endTime":"0","summary":"10月29日, 博拓生物股价跌2.36%，报收29.41元，成交金额1997万元，换手率0.63%，振幅3.49%，量比1.07。博拓生物今日主力资金净流入27万元，连续3日净流入，上一交易日主力净流入327万元，今日环比减少91.74%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为38.46%，平均涨幅为2.48%。该股近5个交易日上涨1.34%，主力资金累计净流入440万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出3368万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029154650a1f485e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029154650a1f485e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":1},{"id":"2476473095","title":"博拓生物10月18日获主力加仓172万元 环比增加911.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476473095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476473095?lang=zh_cn&edition=full","pubTime":"2024-10-18 15:18","pubTimestamp":1729235917,"startTime":"0","endTime":"0","summary":"10月18日, 博拓生物股价涨3.92%，报收28.35元，成交金额2513万元，换手率0.84%，振幅5.50%，量比1.37。博拓生物今日主力资金净流入172万元，上一交易日主力净流入17万元，今日环比增加911.76%。该股近5个交易日上涨1.91%，主力资金累计净流出295万元；近20日主力资金累计净流出3640万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410181529329f4c6b1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410181529329f4c6b1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2474658562","title":"博拓生物大跌5.09% 融资融券实现3连增","url":"https://stock-news.laohu8.com/highlight/detail?id=2474658562","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474658562?lang=zh_cn&edition=full","pubTime":"2024-10-09 10:39","pubTimestamp":1728441553,"startTime":"0","endTime":"0","summary":"10月09日，博拓生物股价大幅下跌，截至10点39分，博拓生物下跌5.09%，报30.55元/股，成交2907万元，换手率0.87%，振幅4.44%。融资融券方面，博拓生物10月08日获得融资净买入250万元，当日该股融资余额为6280万元，当较前一日增加4.15%，实现3连增。最新财报显示，今年中报，博拓生物实现营业收入2.67亿元，同比增长25.97%，净利润为7,217.51万元，同比增长17.16%，基本每股收益为0.69元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009120620ab68b2a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009120620ab68b2a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2471117298","title":"博拓生物创4个月新高 主力资金净流出737万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471117298","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471117298?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:30","pubTimestamp":1727659808,"startTime":"0","endTime":"0","summary":"09月30日，博拓生物股价大幅上涨，截至09点30分，博拓生物上涨6.26%，报28.67元/股，创近4个月新高，成交42万元，换手率0.01%，振幅1.00%。资金动向截止发稿，博拓生物获得主力净流出737万元，其中超大单流出456万元，大单流出280万元。主营业务及业绩博拓生物公司主营业务为从事POCT诊断试剂的研发、生产和销售。最新财报显示，今年中报，博拓生物实现营业收入2.67亿元，同比增长25.97%，净利润为7,217.51万元，同比增长17.16%，基本每股收益为0.69元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930100729ab66ef65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930100729ab66ef65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2470235203","title":"博拓生物(688767.SH)拟推2024年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2470235203","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470235203?lang=zh_cn&edition=full","pubTime":"2024-09-25 17:25","pubTimestamp":1727256352,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博拓生物(688767.SH)发布2024年员工持股计划(草案)，参加本员工持股计划的对象范围为公司(含子公司)监事、高级管理人员及董事会认为需要激励的其他人员，初始设立时总人数不超过19人(不含预留份额)。本员工持股计划股票来源为公司回购专用账户回购的博拓生物A股普通股股票。本员工持股计划拟持有的标的股票数量不超过215万股，约占本员工持股计划草案公布日公司股本总额的2.02%。本员工持股计划购买回购股份的价格为13.09元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1186983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2466905901","title":"博拓生物（688767）6640万股限售股将于9月9日解禁，占总股本62.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2466905901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466905901?lang=zh_cn&edition=full","pubTime":"2024-09-09 08:03","pubTimestamp":1725840231,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，博拓生物于9月9日将有6640.0万股限售股份解禁，为公司首发原股东限售股份，占公司总股本62.25%。本次解禁后，公司已无限售股份。博拓生物主营业务：POCT试剂及仪器的研发、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090900001522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2463471565","title":"博拓生物（688767）2024年中报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2463471565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463471565?lang=zh_cn&edition=full","pubTime":"2024-08-31 06:20","pubTimestamp":1725056410,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期博拓生物发布2024年中报。根据财报显示，博拓生物营收净利润同比双双增长。截至本报告期末，公司营业总收入2.67亿元，同比上升25.97%，归母净利润7217.51万元，同比上升17.16%。其中，毛利率48.65%，同比增18.65%，净利率26.37%，同比减8.28%，销售费用、管理费用、财务费用总计952.08万元，三费占营收比3.56%，同比增148.08%，每股净资产22.15元，同比减1.12%，每股经营性现金流0.87元，同比增587.07%，每股收益0.69元，同比增18.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083100008610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767"],"gpt_icon":0},{"id":"2463280738","title":"博拓生物：\n目前公司主营业务产品以免疫层析技术检测产品为主","url":"https://stock-news.laohu8.com/highlight/detail?id=2463280738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463280738?lang=zh_cn&edition=full","pubTime":"2024-08-30 19:02","pubTimestamp":1725015737,"startTime":"0","endTime":"0","summary":"证券之星消息，博拓生物08月30日在投资者关系平台上答复投资者关心的问题。目前公司主营业务产品以免疫层析技术检测产品为主。目前公司已开发出猴痘病毒抗原和抗体快速检测试剂、猴痘病毒核酸检测试剂并已获得CE认证，可以在认可CE认证的国家和地区进行销售，感谢您的关注！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000039549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2463247379","title":"博拓生物大跌5.09% 融资净买入增加0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463247379","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463247379?lang=zh_cn&edition=full","pubTime":"2024-08-30 09:32","pubTimestamp":1724981579,"startTime":"0","endTime":"0","summary":"08月30日，博拓生物股价大幅下跌，截至09点32分，博拓生物下跌5.09%，报25.53元/股，成交292万元，换手率0.28%，振幅4.57%。资金动向截止发稿，博拓生物获得主力净流出26万元。融资融券方面，博拓生物08月28日获得融资净买入16万元，当日该股融资余额为4975万元，当较前一日增加0.33%。最新财报显示，今年中报，博拓生物实现营业收入2.67亿元，同比增长25.97%，净利润为7,217.51万元，同比增长17.16%，基本每股收益为0.69元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240830093919a1d77220&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240830093919a1d77220&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2463293017","title":"图解博拓生物中报：第二季度单季净利润同比减34.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463293017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463293017?lang=zh_cn&edition=full","pubTime":"2024-08-30 01:56","pubTimestamp":1724954173,"startTime":"0","endTime":"0","summary":"证券之星消息，博拓生物2024年中报显示，公司主营收入2.67亿元，同比上升25.97%；归母净利润7217.51万元，同比上升17.16%；扣非净利润7010.48万元，同比上升31.57%；其中2024年第二季度，公司单季度主营收入1.32亿元，同比上升21.35%；单季度归母净利润3254.37万元，同比下降34.52%；单季度扣非净利润3066.5万元，同比下降30.66%；负债率6.06%，投资收益102.22万元，财务费用-3385.22万元，毛利率48.65%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000002975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767"],"gpt_icon":0},{"id":"2463253942","title":"博拓生物(688767.SH)发布半年度业绩，净利润7218万元，同比增长17.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463253942","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463253942?lang=zh_cn&edition=full","pubTime":"2024-08-29 20:53","pubTimestamp":1724936025,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博拓生物(688767.SH)披露2024年半年度报告，报告期公司实现营收2.67亿元，同比增长25.97%;归母净利润7218万元，同比增长17.16%;扣非净利润7010万元，同比增长31.57%;基本每股收益0.69元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1175469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688767"],"gpt_icon":0},{"id":"2462348671","title":"博拓生物08月27日主力资金流入2万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2462348671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462348671?lang=zh_cn&edition=full","pubTime":"2024-08-27 15:19","pubTimestamp":1724743166,"startTime":"0","endTime":"0","summary":"08月27日, 博拓生物股价涨0.11%，报收26.56元，成交金额1153万元，换手率1.07%，振幅4.15%，量比1.06。博拓生物今日主力资金净流入2万元，连续3日净流入，上一交易日主力净流入94万元，今日环比减少97.87%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为45.45%，平均涨幅为2.56%。该股近5个交易日下跌1.92%，主力资金累计净流入26万元；近20日主力资金累计净流入546万元，其中净流入天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082715474295c8523d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082715474295c8523d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0},{"id":"2459419161","title":"博拓生物08月15日获主力加仓202万元 环比增加778.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459419161","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459419161?lang=zh_cn&edition=full","pubTime":"2024-08-15 15:19","pubTimestamp":1723706351,"startTime":"0","endTime":"0","summary":"08月15日, 博拓生物股价涨0.62%，报收25.79元，成交金额1375万元，换手率1.31%，振幅2.93%，量比1.47。博拓生物今日主力资金净流入202万元，上一交易日主力净流入23万元，今日环比增加778.26%。|08月15日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|凯旺科技|7.05%|#|海辰药业|6.01%|#|天舟文化|4.83%|#|世纪鼎利|4.49%|#|川润股份|4.16%|#|天利科技|3.92%|#|瀛通通讯|3.55%|#|正业科技|3.26%|#|国中水务|3.17%|#|华金资本|2.86%|博拓生物所在的医疗器械行业，今日主力净流入7078万元，行业排名36/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815153557959aa02b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815153557959aa02b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688767"],"gpt_icon":0},{"id":"2459646211","title":"猴痘概念盘中跳水，博拓生物跌0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459646211","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459646211?lang=zh_cn&edition=full","pubTime":"2024-08-14 09:44","pubTimestamp":1723599867,"startTime":"0","endTime":"0","summary":"08月14日，猴痘概念盘中跳水，截至09点44分，猴痘概念整体指数下跌0.53%，报772.990点。从个股上来看，该概念的成分股中，博拓生物跌0.89%，丽珠集团、迈克生物、中国医药跌幅居前。从资金上来看，截止发稿，猴痘概念主力净流入为-4303.53万，其中凯普生物受到资金热捧，主力净流入430.24万；拉长时间线来看，该板块近20日主力资金净流入-10.91亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814094427942005b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814094427942005b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-09-08","address":"浙江省杭州市余杭区中泰街道富泰路17号","stockEarnings":[{"period":"1week","weight":0.021},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.1752},{"period":"6month","weight":0.1053},{"period":"1year","weight":0.014},{"period":"ytd","weight":0.0418}],"companyName":"杭州博拓生物科技股份有限公司","boardCode":"AI0027","perCapita":"14735股","boardName":"医药制造业","registeredCapital":"10666万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":"　　杭州博拓生物科技股份有限公司主营业务是POCT诊断试剂的研发、生产和销售。主要产品为生殖健康快速检测试剂-棒型、生殖健康、毒品、传染病、心肌、肿瘤快速检测试剂-滴板型、生殖健康、毒品、传染病快速检测试剂条型、毒品快速检测试剂插板型、毒品快速检测试剂杯型等。公司相继被认定为浙江省“专精特新”企业、“浙江省企业技术中心”。","serverTime":1732298262797,"listedPrice":34.55,"stockholders":"7239人(较上一季度减少6.83%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博拓生物,688767,博拓生物股票,博拓生物股票老虎,博拓生物股票老虎国际,博拓生物行情,博拓生物股票行情,博拓生物股价,博拓生物股市,博拓生物股票价格,博拓生物股票交易,博拓生物股票购买,博拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}